Function and Morphology of the Meibomian Glands Using a LipiView Interferometer in Rotating Shift Medical Staff

Table 1

Comparison between medical staff (MS) group and control group.

	MS group	Control group	value
N/eyes	31/62	31/59
M : F	10:21	20:11	0.011^&
Age (y)	26.55 ± 3.15	21.91 ± 4.33	0.001
BMI	20.92 ± 2.00	21.19 ± 2.72	0.607^#
DE parameters
TBUT(s)	4.63 ± 3.58	7.83 ± 3.33	0.001
Schirmer I (mm)	19.97 ± 10.17	17.77 ± 6.58	0.178
SPEED (score)	7.94 ± 3.81	3.65 ± 2.11	0.000
OSDI (score)	22.39 ± 13.42	9.87 ± 6.64	0.001
MGD parameters
Max ICU (nm)	76.03 ± 18.73	90.06 ± 13.91	0.001
Mean ICU (nm)	55.02 ± 21.17	72.76 ± 21.62	0.001
Min ICU (nm)	44.58 ± 18.42	58.23 ± 19.28	0.001
PB rate (%)	63.72 ± 35.81	68.18 ± 35.29	0.534
MGYLS (score)	5.43 ± 3.98	8.33 ± 4.50	0.001
MGYCS (score)	4.68 ± 4.09	6.00 ± 4.74	0.112
MGYSS (score)	15.48 ± 11.78	22.50 ± 13.01	0.002

MS: medical staff; N: number; M: male; F: female; BMI: body mass index; TBUT: tear film break-up time; SPEED: standard patient evaluation of eye dryness; OSDI: Ocular Surface Disease Index; ICU: interferometry color units; PB: partial blink; MGD: meibomian gland dysfunction; MGYLS: meibomian gland yielding liquid secretion; MGYCS: meibomian gland yielding clear liquid secretion; and MGYSS: meibomian gland yielding secretion score. ^&Chi-square test; Wilcoxon signed-rank test; ^#Independent-sample t-test.